RANBP3 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, we used GEO data to show the possible role of RanBP3 in patients with IM treatment and did substantiate that down-regulation of RanBP3 improved apoptosis of IM-treated CML cells.